RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

SabioTrade vs Monevis Funding

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

SBTR

SabioTrade

MNVF

Monevis Funding

EST. 2024

SABIOTRADE

METRIC

MONEVIS FUNDING

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

SABIOTRADE DETAILS

STEPS: -phase

MONEVIS FUNDING DETAILS

STEPS: -phase
DRAWDOWN: Static

SabioTrade PROS

+Insufficient data provided to identify meaningful advantages for this firm.
+Insufficient data provided to identify meaningful advantages for this firm.
+Insufficient data provided to identify meaningful advantages for this firm.
+Insufficient data provided to identify meaningful advantages for this firm.

SabioTrade CONS

−No data was provided for this firm, making meaningful comparison impossible.
−Traders cannot assess key metrics such as profit split, drawdown, or funding levels.
−Lack of data represents a significant transparency concern for prospective traders.

Monevis Funding PROS

+Static drawdown type provides a fixed, predictable risk boundary, which some traders prefer for planning.
+Czech Republic is an EU-member jurisdiction, which may offer relevant regulatory context.
+No platform or market data is available to assess further strengths.
+No funding or cost data is provided to compare against industry benchmarks.

Monevis Funding CONS

−Founded in 2024, making Monevis Funding a very new firm with limited operational track record.
−No profit split, max funding, or challenge cost data is available for comparison against industry averages.
−Lack of transparency around key metrics is a concern for traders making informed decisions.

PROPDNA VERDICT